#AAO25: Roche’s eye drug yields one hit, one miss in pivotal trialsnews2025-10-17T20:20:59+00:00October 17th, 2025|Endpoints News|
Robotic pill maker Rani teams up with Chugai in deal worth up to $1.08Bnews2025-10-17T15:21:42+00:00October 17th, 2025|Endpoints News|
Praxis reports double wins in Phase 3 essential tremor trials, sending stock upnews2025-10-16T15:14:10+00:00October 16th, 2025|Endpoints News|
Are PD-1xVEGF bispecifics being tested in the wrong kinds of cancer?news2025-10-16T14:47:42+00:00October 16th, 2025|Endpoints News|
Novartis’ Fabhalta gets confirmatory late-stage trial win in kidney disease IgANnews2025-10-16T13:03:03+00:00October 16th, 2025|Endpoints News|
J&J says Darzalex, Tecvayli combo improves survival odds in multiple myelomanews2025-10-16T12:00:04+00:00October 16th, 2025|Endpoints News|
Aicuris’ herpes drug succeeds in Phase 3 study, company saysnews2025-10-16T09:00:40+00:00October 16th, 2025|Endpoints News|
Peter Thiel-backed Peptilogics raises $78M for prosthetic joint infection programnews2025-10-16T09:00:13+00:00October 16th, 2025|Endpoints News|
Lilly’s oral GLP-1 racks up two more clinical wins in diabetesnews2025-10-15T14:51:43+00:00October 15th, 2025|Endpoints News|
Bexorg raises $23M to test drugs on ‘rebooted’ human brains from organ donorsnews2025-10-15T11:00:50+00:00October 15th, 2025|Endpoints News|
